G-FINDER data portal: tracking funding for global health R&D

The G-FINDER project tracks R&D funding for new products and technologies that address global health challenges disproportionately affecting the world's most disadvantaged populations. The G-FINDER data portal provides open access to all data captured by the G-FINDER project between 2007 and 2023 and is updated annually towards the end of the year.

or select a quick filter:

Impact Global Health uses the data captured by the G-FINDER project to produce a range of independent reports, including the G-FINDER neglected diseases, emerging infectious diseases, and sexual & reproductive health reports. Please include the following reference when citing or using text, figures, or data from this site:
Impact Global Health, G-FINDER data portal, https://gfinderdata.impactglobalhealth.org

HIV R&D funding dropped to an all-time low in 2023, driven by significant decreases from the two top funders: industry and US NIH

Industry investment in late-stage clinical testing of Bedaquiline contributed to the highest-ever funding recorded for leprosy R&D

Funding for TB rebounded in 2023 to reach $806m, driven by a 62% rise in vaccine R&D, which, building on last year?s growth, reached a record $153m